-
EP3985019
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP3985019
| EP3985019 - RECOMBINANT HUMAN COLLAGEN AND CONSTRUCTION METHOD THEREFOR [Right-click to bookmark this link] | Status | Grant of patent is intended Status updated on 03.06.2024 Database last updated on 29.07.2024 | |
| Former | Request for examination was made Status updated on 18.03.2022 | ||
| Former | The international publication has been made Status updated on 29.10.2021 | Most recent event Tooltip | 03.06.2024 | New entry: Communication of intention to grant a patent | Applicant(s) | For all designated states Nantong University No. 9 Liyuan Road Nantong, Jiangsu 226019 / CN | [2022/16] | Inventor(s) | 01 /
GU, Xiaosong No. 9, Seyuan Road Nantong, Jiangsu 226019 / CN | 02 /
QIAN, Tianmei No. 9, Seyuan Road Nantong, Jiangsu 226019 / CN | 03 /
WANG, Hongkui No. 9, Seyuan Road Nantong, Jiangsu 226019 / CN | 04 /
SUN, Hualin No. 9, Seyuan Road Nantong, Jiangsu 226019 / CN | 05 /
GU, Yun No. 9, Seyuan Road Nantong, Jiangsu 226019 / CN | [2022/16] | Representative(s) | Grünecker Patent- und Rechtsanwälte PartG mbB Leopoldstraße 4 80802 München / DE | [2022/16] | Application number, filing date | 20932054.8 | 09.06.2020 | [2022/16] | WO2020CN95014 | Priority number, date | CN202010331037 | 24.04.2020 Original published format: CN202010331037 | [2022/16] | Filing language | ZH | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2021212627 | Date: | 28.10.2021 | Language: | ZH | [2021/43] | Type: | A1 Application with search report | No.: | EP3985019 | Date: | 20.04.2022 | Language: | EN | [2022/16] | Search report(s) | International search report - published on: | CN | 28.10.2021 | (Supplementary) European search report - dispatched on: | EP | 02.11.2022 | Classification | IPC: | C07K14/78 | [2022/16] | CPC: |
C07K14/78 (EP,CN);
Y02A50/30 (EP)
| Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2022/16] | Title | German: | REKOMBINANTES MENSCHLICHES KOLLAGEN UND VERFAHREN ZU DESSEN HERSTELLUNG | [2022/16] | English: | RECOMBINANT HUMAN COLLAGEN AND CONSTRUCTION METHOD THEREFOR | [2022/16] | French: | COLLAGÈNE HUMAIN RECOMBINANT ET SON PROCÉDÉ DE CONSTRUCTION | [2022/16] | Entry into regional phase | 14.01.2022 | Translation filed | 14.01.2022 | National basic fee paid | 14.01.2022 | Search fee paid | 14.01.2022 | Designation fee(s) paid | 14.01.2022 | Examination fee paid | Examination procedure | 14.01.2022 | Examination requested [2022/16] | 22.05.2023 | Amendment by applicant (claims and/or description) | 04.06.2024 | Communication of intention to grant the patent | Fees paid | Renewal fee | 14.01.2022 | Renewal fee patent year 03 | 28.06.2023 | Renewal fee patent year 04 | 31.03.2024 | Renewal fee patent year 05 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Documents cited: | Search | [A]US5710252 (WEBER SHANE CRAWFORD [US], et al) [A] 1-10* see "Summary of the invention" and the claims. *; | [A]WO2016090892 (CHENGDU XINJI BIOACTIVE COLLAGEN DEV CO LTD [CN]) [A] 1-10 * see "Summary", Examples 1 to 3 and claims 1-6. *; | [A] - TAKEOKA YOSHIKI ET AL, "Reduced nucleotomy-induced intervertebral disc disruption through spontaneous spheroid formation by the Low Adhesive Scaffold Collagen (LASCol)", BIOMATERIALS, AMSTERDAM, NL, (20200301), vol. 235, doi:10.1016/j.biomaterials.2020.119781, ISSN 0142-9612, page 119781, XP055970001 [A] 1-10 * see "Abstract" and "Conclusion" * DOI: http://dx.doi.org/10.1016/j.biomaterials.2020.119781 | [A] - YAN WANG ET AL, "Nanoparticle-Based Delivery System for Application of siRNA In Vivo", CURRENT DRUG METABOLISM, US, (20100201), vol. 11, no. 2, doi:10.2174/138920010791110863, ISSN 1389-2002, pages 182 - 196, XP055681520 [A] 1-10 * see paragraph "Atelocollagen" page 186 * DOI: http://dx.doi.org/10.2174/138920010791110863 | International search | [A]US6992172 (CHANG ROBERT C [US], et al) [A] 1-10 * entire document *; | [A]WO2009053985 (COLLPLANT LTD [IL], et al) [A] 1-10 * entire document *; | [A]CN102925451 (SHAANXI DONGDA BIOCHEMICAL TECHNOLOGY CO LTD) [A] 1-10 * entire document *; | [A]CN110194795 (GUO WEI) [A] 1-10 * entire document *; | [A]CN111004319 (JIANGSU YUEZHI BIOLOGICAL MEDICINE CO LTD) [A] 1-10 * entire document *; | [A] - Hubmacher Dirk, Sabatier Laetitia, Annis Douglas S., Mosher Deane F., Reinhardt Dieter P., "Homocysteine Modifies Structural and Functional Properties of Fibronectin and Interferes with the Fibronectin-Fibrillin-1 Interaction", Biochemistry, (20110614), vol. 50, no. 23, doi:10.1021/bi200183z, ISSN 0006-2960, pages 5322 - 5332, XP055859959 [A] 1-10 * pp. 5322-5332 * DOI: http://dx.doi.org/10.1021/bi200183z | [A] - Kulke Martin, Geist Norman, Friedrichs Wenke, Langel Walter, "Molecular dynamics simulations on networks of heparin and collagen : MD on Networks of Heparin and Collagen", Proteins: Structure, Function, and Bioinformatics, US , (20170601), vol. 85, no. 6, doi:10.1002/prot.25277, ISSN 0887-3585, pages 1119 - 1130, XP055859962 [A] 1-10 * pp. 1119-1130 * DOI: http://dx.doi.org/10.1002/prot.25277 | [A] - WAN, Tao et al., "The Multi-Parameter Prediction of Potential Protein Antigenic Determinants", Chinese Journal of Immunology, (19971231), vol. 13, no. 6, pages 329 - 333, XP055859967 [A] 1-10 * pp. 329-333 * |